Copy
Welcome to our October 2021 Newsletter!
Watch for a new mini edition each month...
View this email in your browser

In This Issue

  • Expansion Update
  • COVID-19 Update
  • NSIV New Member
  • Keeping up with NSIV
  • What's going on

NSIV Website

Find all these stories and more on our website! Stay informed at NSIV.org.

Keep Up With Us

LinkedIn LinkedIn
Twitter Twitter
Facebook Facebook
YouTube YouTube
Expansion Update
With the help of our partners and Cummings, LLC, NSIV's 5000 square foot construction project with 600 square feet of dedicated condo space has been completed.  Stay tuned for the date of the ribbon-cutting event.
       Chris Ilsley (right), NSIV President & CEO, receives the keys from
           Justin D'Aveta, Cummings Leasing/Property Manager.
COVID-19 Update

NSIV is requiring all member companies to have a written COVID policy for their employees, and to have that policy approved by NSIV.  For those companies that have employees that are not vaccinated, Member companies must report the percentage of employees fully vaccinated to NSIV.  If the number is below 100%, Member companies must also report to NSIV the test status of all unvaccinated employees within 8 hours of receiving the test results from employees.
NSIV New Member
At age 27, David Hysong, the President and CEO of SHEPHERD Therapeutics, was diagnosed with Adenoid Cystic Carcinoma (ACC)—an ultra-rare, untreatable head and neck cancer. David’s form of cancer, like so many others, did not respond to chemotherapy and had no approved targeted therapies.  He founded Shepherd to discover, develop, and connect lifesaving cures for rare cancer patients.  Shepherd pursues its drug development in a platform-agnostic manner, letting biology drive how it targets specific rare cancers using state-of-the-art technology.        

Keeping Up with NSIV
 

Megan O'Connor, CEO and CoFounder of Nth Cycle, was a guest on TechCrunch's Found in a segment that was entitled "How one founder aims to help ensure you can keep upgrading your smartphone regularly."  Read the whole segment here.
Radical Plastics will be a partner in a new plastics biodegradation laboratory at UMass Dartmouth.  The lab funded by the Commonwealth of Massachusetts will enable efficient testing of plastic biodegradation, helping address the significant waste caused by traditional plastics used in textiles, packaging, and other products that accumulate in the ocean and other water resources.  Read the full press release here.
What's Going On?
                         

Life Science Consortium of the North Shore (LSCNS) was awarded one of Cell Signaling Technology's Education in Science (EIS) grants for 10K.  Cell Signaling Technology, Inc. (CST) is a global discovery technology company and leading provider of antibodies, kits, and services, headquartered in Danvers, MA.  These grants are awarded annually to support STEM educational efforts in local North Shore communities. EIS grants are a part of CST’s overall charitable programs that are designed to inspire the next generation of scientists, making it critical to the future of sustained scientific discovery.
 



ACTION Innovation Network is pleased to sponsor and invite you to join us at Venture Summit \ Virtual Connect

Special offer: Register Now & Save $100 off (Use discount code “ACTVIP")
  
                                 Startups \ Investors \ Matchmaking
                                                Venture Summit
                                                Virtual Connect
 
                                           December 7th - 9th 2021

Apply to Present / Nominate a company:
For more information or to be considered for one of the Top Innovator slots click here
 
MassBio announced a relaunch of its mentorship program. Now called MassBioDrive, this enhanced program is a component of MassBio's Innovation Services programming and is designed to provide early-stage entrepreneurs and academics a more robust set of resources, tools, and networks earlier in their growth trajectory to fully realize the potential of their science. Learn more about MassBio's Innovation Services programming or reach out to Massbio at drive@massbio.org.
Copyright © 2021 North Shore InnoVentures, All rights reserved. 
You are receiving our newsletter because you have indicated that you wished to receive updates on NSIV events and news. Please let us know how we can best keep you up to date! 
Our mailing address is: 
North Shore InnoVentures
100 Cummings Center
Suite 451C
Beverly, MA 01915
Add us to your address book
Email Marketing Powered by MailChimp
 unsubscribe from this list | update subscription preferences 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
North Shore InnoVentures · 100 Cummings Center · Suite 451C · Beverly, MA 01915 · USA

Email Marketing Powered by Mailchimp